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atherosclerosis risk in young adults: examining causal links
using Mendelian randomization in the Cardiovascular Risk
in Young Finns study’† by M. Kivima¨ki et al., on page 2552
For obvious ethical reasons, risk factors cannot be assessed in
randomized controlled trials. Epidemiologists therefore usually
identify risk factors using observational data. It is, however,
difficult to establish causal relationships between risk factors and
common complex diseases because observational studies are
prone to spurious results due to confounding factors, reverse
causation, and/or selection biases.1 Atherosclerosis is a common
complex trait influenced by several cardiovascular risk factors
that tend to cluster. In this context, determining whether a putative
risk factor is causaly related to atherosclerosis, independently of all
other risk factors (i.e. ceteris paribus), is a challenging task.
What is Mendelian randomization?
The concept of Mendelian randomization refers to the random
allocation of alleles at the time of gamete formation. By analogy
with the fact that the random allocation of treatment in a random-
ized controlled trial renders confounding unlikely, a genetic variant
of interest should not be associated with known and unknown
confounding factors.2 Mendelian randomization has recently been
proposed as a new tool to overcome some of the problems
encountered in observational epidemiology, such as reducing
residual confounding and protecting against reverse causation.3 In
Mendelian randomization, a functional genetic variant, or a
variant in strong linkage disequilibrium with it, is used to retrieve
an unbiased estimate of the association of a modifiable exposure
[e.g. C-reactive protein (CRP), fibrinogen, or body mass index
(BMI)] with a disease (e.g. coronary heart disease, stroke, or ather-
osclerosis).1 As such, Mendelian randomization may prove a
valuable tool to infer causality in cardiovascular observational
epidemiology. However, it is not, and should not be viewed, as
a panacea, and its limitations should be clearly acknowledged.
The concept of Mendelian randomization is an application of the
theory of instrumental variables.2,4,5 Instrumental variables are
used to make causal inference in non-experimental conditions
and have been widely explored by econometricians.2 As illustrated
in Figure 1 of the paper by Kivima¨ki et al.,6 an instrumental variable
(e.g. rs9939609 FTO variant) is a variable that is associated with the
outcome (e.g. atherosclerosis) only through its association with the
exposure of interest (e.g. lifetime BMI). The reader should keep in
mind that the use of instrumental variables in statistical genetics is
still in its infancy and that more theoretical work is needed in this
context. An important limitation in statistical genetics is the weak-
ness of the instrument, i.e. the genetic variant is only weakly cor-
related with the exposure of interest.
The limitations of Mendelian
randomization
Mendelian randomization studies represent a special case of
genetic association studies and therefore also suffer from similar
limitations. So far, the findings of genetic association studies in
the field of complex traits, including cardiovascular traits, have
been difficult to replicate. Several reasons may explain these diffi-
culties. First, any single genetic variant only explains a small pro-
portion of the trait variance, so that very large sample sizes are
needed to achieve a reasonable power. Secondly, it is not easy
to identify relevant functional genetic variants, so that most associ-
ations are indirect and rest on linkage disequilibrium, which may
vary from one population to the other. Thirdly, complex diseases
are probably influenced by numerous gene–gene and gene–
environment interactions, which again may differ from one popu-
lation to the other. Fourthly, the level of genetic heterogeneity
underlying complex cardiovascular traits is still unclear. Most
genetic association studies rely on the assumption that the
‘common disease, common variant hypothesis’ holds, i.e. the
same variants are causal in affected individuals, which is uncertain.
In addition to the general limitations cited above, the Mendelian
randomization approach in observational epidemiology suffers
from other limitations, some of which are more specific to this
approach:7–9 (i) a suitable genetic variant to study the exposure
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of interest does not always exist; (ii) the association between
selected genetic variants and gene product (or associated trait)
is often not very strong (i.e. the instrument is weak with corre-
lations between genetic variant and gene product usually being
,0.05); (iii) there may be confounding by population stratification;
(iv) there may be confounding by linkage disequilibrium; (v) pleio-
tropy may exist (i.e. the gene of interest influences many pheno-
types); (vi) the genetic variant of interest may affect selective
survival, before or after birth, so that the genotypic frequencies
at entry into the study do not match those obtained after
meiosis; (vii) there may be segregation distortion at the locus of
interest; (viii) there may be canalization and developmental com-
pensation (i.e. a functional adaptation to a specific genotype may
influence the expected genotype–disease association); and (ix) a
parent-of-origin effect may exist.
The present study in perspective
The paper by Kivima¨ki et al.6 describes the effect of lifetime BMI on
carotid intima-media thickness (CIMT) and various atherosclerotic
risk factors in young adults in Finland using both conventional
ordinary least square regression and instrumental variable two-
stage least square regression approaches. The results suggest
that increased BMI during childhood is associated with increased
risk of atherosclerosis in early adulthood. In this study, previous
phenotypic data from a large and long follow-up study are available.
In contrast, genetic data only consist of one single nucleotide poly-
morphism (SNP) located within the FTO gene. Note, however that,
in this study, genotyping additional FTO SNPs and inferring haplo-
types did not improve the strength of the observed signal, which
suggests that the measured FTO SNP and estimated haplotypes
are probably detecting the same signal.
Kivima¨ki et al. have used an original, yet risky, approach in that they
used Mendelian randomization with an exposure (i.e. lifetime BMI)
that is not the direct gene product, unlike some previous studies
on the CRP gene, CRP levels, and various outcomes.10–13 Why is
this approach risky? First, it is risky because the instrument (i.e. the
genetic variant) is very weak, as illustrated by the low proportion
of BMI variance (in this particular case 0.4%) explained by the
rs9939609 FTO variant. As a consequence, the estimated effect size
becomes very imprecise: for instance, although the effect size
obtained for the association of lifetime BMI on adult CIMT using
the instrumental variable approach was substantially higher than the
one obtained using ordinary least square regression, the confidence
interval was much larger and the result not statistically significant. Sec-
ondly, it is risky because, in such a situation, it is difficult to ensure that
the gene (e.g. FTO) effect on the outcome of interest (e.g. CIMT) only
acts via the exposure of interest (e.g. lifetime BMI). Failure to satisfy
this latter condition could lead to biased estimates of effect size.
Despite these potential limitations, the example appears to be
well chosen: (i) the association between this FTO genetic variant
and BMI has been repeatedly observed in independent studies;
(ii) the association of the FTO gene with other phenotypes suscep-
tible to influence carotid atherosclerosis (e.g. diabetes mellitus)
appears to occur via BMI, so that the assumptions underlying
Mendelian randomization should not be violated in this particular
case. This study nicely illustrates how two approaches
(conventional ordinary least square regression and instrumental
variable two-stage least square regression), which suffer from
different limitations, may complement each other. If one is willing
to accept that the assumptions underlying the instrumental variable
approach are met, the results based on Mendelian randomization
suggest that the association between lifetime BMI and CIMT is
causal. It will be of great interest to see if these results can be con-
firmed in other large prospective cohort studies, in particular in
other ethnic groups. The importance of these findings lies in the
potential for early prevention of atherosclerosis via BMI reduction.
Although it is as yet unclear to what extent Mendelian ran-
domization studies can and will improve causal inference in obser-
vational epidemiology, this potential is certainly worth exploring
further. The study by Kivima¨ki et al.6 illustrates how Mendelian ran-
domization can be used to increase our confidence that a specific
association, i.e. lifetime BMI and CIMT, is causal using observational
data. These results suggest that genetic epidemiology may
reinforce the findings of observational epidemiology.
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The above article uses a new reference style being piloted by the
EHJ that shall soon be used for all articles.
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